JAY S SKYLER

CIK 1236386 · last filed 2026-02-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.77M

Companies

4

Total Filings

67

Lifetime Open-Market Net

-$36.44M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Applied Therapeutics, Inc. (APLT) Delisted Director 42,500 $0.10 $4.4K $0 9 2026-02-03
SABSW Director $0.01 $0 2 2025-12-18
DXCM Director 63,348 $75.37 $4.77M -$36.44M 37 2023-05-22
AMYLIN PHARMACEUTICALS INC (AMLN) Delisted Director 121,286 $0 18 2012-05-17

Recent Filings · Page 2 of 7

67 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-06-24 DXCM Sell (S) −20,000 -$8.53M EDGAR
2021-06-04 Applied Therapeutics, Inc. (APLT) Delisted Grant (A) $0 EDGAR
2021-05-25 DXCM Mixed +900 $1 EDGAR
2020-06-05 Applied Therapeutics, Inc. (APLT) Delisted Grant (A) $0 EDGAR
2020-05-27 DXCM Mixed +822 $1 EDGAR
2020-01-07 DXCM Sell (S) −25,806 -$5.62M EDGAR
2019-06-04 DXCM Mixed +2,729 $3 EDGAR
2019-05-15 Applied Therapeutics, Inc. (APLT) Delisted Grant (A) $0 EDGAR
2019-01-04 DXCM Exer (M) +25,806 $118.2K EDGAR
2018-06-26 DXCM Grant (A) +3,607 $4 EDGAR
Showing 1120 of 67
Page 2 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.